Home LiteratureArticle Details
PMID: 12213216 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.

Experimental cell research ·Vol. 279 ·No. 1 ·2002-09-10 ·Pages 80-90

Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES

Abstract

Activation of fatty acid synthase (FAS) expression and fatty acid synthesis is a common event in tumor cells from a variety of human cancers and is closely linked to malignant transformation and to tumor virulence in population studies of human cancer. We now show that, in contrast to nutritional regulation of lipogenesis in liver or adipose tissue, changes in fatty acid metabolism during in vitro transformation of the human mammary epithelial cell line MCF-10a are driven by increases in epidermal growth factor signaling, acting in major part through the mitogen-activated protein (MAP) kinase and phosphatidylinositol (PI) 3-kinase signaling cascades. H-ras transformation of MCF-10a cells resulted in upregulation of MAP kinase and PI 3-kinase signals, upregulation of sterol regulatory element binding protein 1 (SREBP-1) transcription factor levels, and upregulation of FAS expression and FA synthesis. Deletion of the major SREBP binding site from the FAS promoter abrogated transcription in transformed MCF-10a cells. Inhibitors of MAP and PI 3-kinases downregulated SREBP-1 levels and decreased transcription from the FAS promoter, reducing FAS expression and fatty acid synthesis in transformed MCF-10a cells and in MCF-7 and HCT116 carcinoma cells. H-ras transformation sensitized MCF-10a cells to the FAS inhibitors cerulenin and C-75. These results confirm an important role for SREBP-1 in neoplastic lipogenesis, and provide a likely basis for the linkage of upregulated fatty acid metabolism with neoplastic transformation and with tumor virulence, since MAP and PI 3-kinase signaling contributes to both.

MeSH Terms
Breast/cytology,enzymology,metabolism CCAAT-Enhancer-Binding Proteins/biosynthesis Carcinoma/enzymology,metabolism Cell Line, Transformed Cell Transformation, Neoplastic DNA-Binding Proteins/biosynthesis Enzyme Inhibitors/pharmacology Epithelial Cells/cytology,enzymology,metabolism Fatty Acid Synthases/antagonists & inhibitors,metabolism Fatty Acids/biosynthesis Growth Inhibitors/pharmacology Humans Lipid Metabolism MAP Kinase Kinase 1 Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors,physiology Mitogen-Activated Protein Kinases/antagonists & inhibitors,physiology Phosphatidylinositol 3-Kinases/physiology Phosphoinositide-3 Kinase Inhibitors Protein Serine-Threonine Kinases/antagonists & inhibitors,physiology Proto-Oncogene Proteins/antagonists & inhibitors,physiology Proto-Oncogene Proteins c-akt Signal Transduction Sterol Regulatory Element Binding Protein 1 Transcription Factors Tumor Cells, Cultured ras Proteins/physiology
Chemicals
CCAAT-Enhancer-Binding Proteins DNA-Binding Proteins Enzyme Inhibitors Fatty Acids Growth Inhibitors Phosphoinositide-3 Kinase Inhibitors Proto-Oncogene Proteins SREBF1 protein, human Sterol Regulatory Element Binding Protein 1 Transcription Factors Fatty Acid Synthases Protein Serine-Threonine Kinases Proto-Oncogene Proteins c-akt Mitogen-Activated Protein Kinases MAP Kinase Kinase 1 MAP2K1 protein, human Mitogen-Activated Protein Kinase Kinases ras Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yang Yu-An
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21224, USA.
Han Wan Fang
Morin Patrice J
Chrest Francis J
Pizer Ellen S
Article Info
Journal
Experimental cell research
Abbr.
Exp Cell Res
ISSN
0014-4827
Published
2002-09-10
Pages
80-90
Language
English
Region
United States
NLM ID
0373226
Subset
IM
Grants
NCI NIH HHS · PC991429 · United States
NCI NIH HHS · R29CA75219 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com